Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biovie Inc (NQ: BIVI )

2.710 -0.110 (-3.90%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biovie Inc

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
BioVie's Lead Drug Candidate Aims To Treat Neurodegenerative Disease By Targeting Inflammation
Via ACCESSWIRE
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Top 5 Health Care Stocks That May Explode In Q3
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
BioVie and Soligenix Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
BioVie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 6/12
Via Investor Brand Network
BioVie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 5/30
Via Investor Brand Network
BioVie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 5/25
Via Investor Brand Network
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
BioVie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 5/17
Via Investor Brand Network
BioVie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 5/8
Via Investor Brand Network
Benzinga Pro's Top 5 Stocks To Watch For Friday, April 28, 2023: COST, SOFI, COIN, NET, BIVI
Costco Wholesale (COST) - The company will report monthly sales results for April on Wednesday of next week. This has been a news catalyst for Costco over the last few years -- albeit a modest 
Via Benzinga
BioVie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 4/25
Via Investor Brand Network
BioVie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 4/19
Via Investor Brand Network
Biovie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 3/22
Via Investor Brand Network
Biovie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 3/17
Via Investor Brand Network
Biovie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 3/16
Via Investor Brand Network
BioVie Says Its Parkinson's Candidate Eases Morning 'Rigid Muscles'
Via Benzinga
BioVie Inc. and iRemedy Interviews to Air on Bloomberg U.S. on the RedChip Money Report(R)
Via ACCESSWIRE
Why Shares of BioVie Jumped This Week
BioVie's announcement regarding a phase 2 trial for its lead therapy helped raise the stock's price. 
Via The Motley Fool
Why Shares of BioVie Jumped 51.7% in February
The company is forging ahead with a phase 3 trial for its lead therapy. 
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
RedChip CEO Dave Gentry Invited to Join Forbes Business Council
Via ACCESSWIRE
Why Shares of BioVie Rose 15.3% in December
The biotech announced positive news from a pair of phase 2 clinical trials. 
Via The Motley Fool
Analyzing BioVie's Short Interest
BioVie's (NASDAQ:BIVI) short percent of float has risen 27.02% since its last report. The company recently reported that it has 612 thousand shares sold short, which is 6.77% of all regular shares that... 
Via Benzinga
Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group. 
Via Benzinga
BioVie Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
Via ACCESSWIRE
How Is The Market Feeling About BioVie?
BioVie's (NASDAQ:BIVI) short percent of float has risen 67.61% since its last report. The company recently reported that it has 379 thousand shares sold short, which is 5.33% of all regular shares that... 
Via Benzinga
Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.